There are more than 1 Million hospital needlestick injuries that occur in Europe each year and an estimated 25% of incidences go unreported. An approximate 62 – 88% of needlestick injuries are preventable.

The European Vascular Access market is transitioning to the use of more safety and power-injectable devices, driven primarily by legislation designed to prevent needlestick injuries such as catheter securement, power-injectable PICC and PIVC devices that aim to reduce the number of sharp injuries.


For information on this report please request a free table of contents for the European Vascular Access Devices Market 2014 Report.

Scope: This report pertains to a forecast period of 10 years 2010 – 2020

Countries: Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux(Belgium, Netherlands and Luxemburg), Scandinavia (Denmark, Finland, Norway and Sweden).